PEG — Pharma Equity A/S Share News
0.000.00%
Last trade - 00:00- DKK95.99m
- DKK106.71m
Brief: Pharma Equity Group's Reponex Reports Highly Positive Final Results From Phase-2 Clinical Trial Of Co's Patented Drug Candidate RNX-051
Brief: Pharma Equity Signs Deal With Danske Bank On Market Maker In Peg Share
Brief: Pharma Equity Net Loss For Year Widens To DKK 24.6 Mln
Brief: Pharma Equity Subsidiary Gets Patent For Drug Compositions
Brief: Pharma Equity Group To Issue Convertible Loans
Brief: Pharma Equity Says Convertible Loans Are Fully Subscribed For
Brief: Pharma Equity Announces BOD Decision To Issue Convertible Loans
Brief: Pharma Equity Group's Subsidiary Meets Primary Endpoints In Phase-2 Clinical Trial
Brief: Pharma Equity Group Consolidated Q3 Interim Report
Brief: Pharma Equity Unit Reponex Receives Grant Of U.S. Patent
Brief: Pharma Equity Group A/S It Is Expectation, That Receivable Will Be Repaid Shortly And Probably Not Later Than December 2023
Brief: Pharma Equity H1 Loss After Tax At DKK 7.2 Million
Brief: Pharma Equity: Unit Reponex Receives USPTO Notice Of Allowance
Brief: Pharma Equity Chairman Of BOD Peter Mørch Eriksen Resigns
Brief: Pharma Equity Group Announces Preliminary Data From First Part Of Clinical Study In Pouchitis
Brief: Pharma Equity Group Achieved In Q1-2023 A Loss After Tax Of DKK 2.9 Million
Brief: Pharma Equity Group Board Elects New CEO, Chair
Brief: Blue Vision H1 Result Turns To Profit At SEK 1.8 Mln
Brief: Blue Vision Makes Conditional Purchase Offer For Reponex Pharmaceuticals